معرفی
Dr. Tom Palmer is a Senior Lecturer in Biostatistics Applied to Genetics at the University of Bristol's Bristol Medical School. He holds advanced degrees including a PhD and specializes in biostatistical methodologies for genetic and epidemiological research. His work integrates Mendelian randomization techniques and large-scale observational studies, particularly focusing on cardiovascular diseases, diabetes, and the impacts of the SARS-CoV-2 pandemic.
Palmer's research emphasizes causal inference and methodological innovations in public health, leveraging electronic health record systems like OpenSAFELY to analyze vaccine efficacy, post-infection complications, and chronic disease outcomes. His studies often involve large cohorts (e.g., 16 million people in England) and address critical questions about the long-term health effects of infectious diseases and vaccination strategies.
- Education: PG Cert, PhD, MSc, BSc (specific degree institutions not explicitly stated)
- Affiliations: Bristol Medical School (PHS), OpenSAFELY initiative
His research interests include:
- Mendelian randomization and causal inference methods
- Genetic epidemiology of obesity, cardiovascular disease, and diabetes
- Evaluation of vaccine effectiveness and safety
- Public health responses to pandemics
Palmer collaborates closely with leading epidemiologists and statisticians at the University of Bristol, including Professors George Davey Smith, Kate Tilling, and Jonathan Sterne. His work has significant implications for healthcare policy and clinical decision-making in post-pandemic and chronic disease management contexts.
